A Hybrid Protein–Polymer Nanoworm Potentiates Apoptosis Better than a Monoclonal Antibody

[Image: see text] B-cell lymphomas continue to occur with a high incidence. The chimeric antibody known as Rituximab (Rituxan) has become a vital therapy for these patients. Rituximab induces cell death via binding and clustering of the CD20 receptor by Fcγ expressing effector cells. Because of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Aluri, Suhaas Rayudu, Shi, Pu, Gustafson, Joshua A., Wang, Wan, Lin, Yi-An, Cui, Honggang, Liu, Shuanglong, Conti, Peter S., Li, Zibo, Hu, Peisheng, Epstein, Alan L., MacKay, John Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004287/
https://www.ncbi.nlm.nih.gov/pubmed/24484356
http://dx.doi.org/10.1021/nn403973g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004287/
https://www.ncbi.nlm.nih.gov/pubmed/24484356
http://dx.doi.org/10.1021/nn403973g

Ejemplares similares